Combination Antimalarials in Uncomplicated Malaria
Status:
Completed
Trial end date:
2005-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to study the efficacy of sulfadoxine-pyrimethamine on its own
and compare this with efficacy of a new combination antimalarial therapy, either
sulphadoxine-pyrimethamine plus artesunate or artemether-lumefantrine.
Phase:
N/A
Details
Lead Sponsor:
University of Cape Town
Collaborators:
Global Fund Medical Research Council, South Africa World Health Organization
Treatments:
Artemether Artemether-lumefantrine combination Artemether, Lumefantrine Drug Combination Artemisinins Artesunate Fanasil, pyrimethamine drug combination Lumefantrine Pyrimethamine Sulfadoxine